To further verify the discriminating power of FABP4 and FABP6 identified for CRC diagnosis, serum levels of FABP4 and FABP6 were assessed on an independent group of 200 serum samples including 100 CRC patients and 100 normal controls. The gene discussed is FABP6; the disease is colorectal carcinoma.